Although there have been algorithms developed to assist clinicians in insulin doses, they are mostly limited to simulated settings without any human evaluations, include exclusively patients with diabetes, and none specifically target post-cardiac surgery patients46–48. This evidence concerns the gene INS and diabetes mellitus.